Cargando…
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy
Expression of N-glycolyl GM3 (NeuGcGM3) ganglioside was detected in the tumor specimens of patients who were on Racotumomab anti-idiotype vaccine maintenance treatment, and prognostic significance as a biomarker was investigated. No statistically significant association was observed in the multivari...
Autores principales: | Uskent, Necdet, Ayla, Sule, Molinas Mandel, Nil, Ozkan, Metin, Teomete, Mehmet, Baloglu, Huseyin, Aydıncer, Cenk, Yergok, Hale, Dogan, Ender, Berk, Barkın, Yazar, Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341415/ https://www.ncbi.nlm.nih.gov/pubmed/32670370 http://dx.doi.org/10.1155/2020/1360431 |
Ejemplares similares
-
Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
por: Palomo, Addys González, et al.
Publicado: (2016) -
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013) -
P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
por: Martínez, Darel, et al.
Publicado: (2012) -
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012) -
Immune response to racotumomab in a child with relapsed neuroblastoma
por: Sampor, C., et al.
Publicado: (2012)